rs746165832
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001387283.1(SMARCA4):c.4240C>G(p.Leu1414Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,450,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1414F) has been classified as Likely benign.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.4240C>G | p.Leu1414Val | missense_variant | Exon 30 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000643549.1 | c.4141C>G | p.Leu1381Val | missense_variant | Exon 29 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.4171-1780C>G | intron_variant | Intron 29 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000541122.6 | c.4072-1771C>G | intron_variant | Intron 29 of 34 | 5 | ENSP00000445036.2 | ||||
| SMARCA4 | ENST00000643296.1 | c.4072-1771C>G | intron_variant | Intron 28 of 33 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.4072-1771C>G | intron_variant | Intron 28 of 33 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000589677.5 | c.4072-1771C>G | intron_variant | Intron 29 of 34 | 5 | ENSP00000464778.1 | ||||
| SMARCA4 | ENST00000643995.1 | c.3583-1771C>G | intron_variant | Intron 26 of 31 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.2815-1771C>G | intron_variant | Intron 22 of 27 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.2797-1771C>G | intron_variant | Intron 21 of 26 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.2656-1771C>G | intron_variant | Intron 21 of 26 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.2524-1771C>G | intron_variant | Intron 20 of 24 | ENSP00000494159.1 | |||||
| SMARCA4 | ENST00000538456.4 | c.328-1771C>G | intron_variant | Intron 3 of 7 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000427 AC: 1AN: 234212 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1450932Hom.: 0 Cov.: 29 AF XY: 0.00000139 AC XY: 1AN XY: 721542 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This variant is present in population databases (rs746165832, gnomAD 0.003%). This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1414 of the SMARCA4 protein (p.Leu1414Val). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 408704). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L1414V variant (also known as c.4240C>G), located in coding exon 29 of the SMARCA4 gene, results from a C to G substitution at nucleotide position 4240. The leucine at codon 1414 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at